BlackRock Institutional Trust’s ResMed RMD Stock Holding History

BlackRock Institutional Trust’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$283M	Buy	4,566,701 +225,088	+5%	+$13.8M	0.04%	440
2016 Q3	$281M	Sell	4,341,613 -22,726	-0.5%	-$1.51M	0.04%	430
2016 Q2	$276M	Buy	4,364,339 +93,967	+2%	+$5.54M	0.04%	414
2016 Q1	$247M	Buy	4,270,372 +149,999	+4%	+$8.49M	0.04%	457
2015 Q4	$221M	Buy	4,120,373 +65,690	+2%	+$3.7M	0.04%	493
2015 Q3	$207M	Buy	4,054,683 +33,074	+0.8%	+$1.78M	0.04%	509
2015 Q2	$227M	Sell	4,021,609 -26,877	-0.7%	-$1.7M	0.04%	513
2015 Q1	$291M	Buy	4,048,486 +199,276	+5%	+$12.9M	0.05%	419
2014 Q4	$216M	Buy	3,849,210 +5,688	+0.1%	+$297K	0.03%	511
2014 Q3	$189M	Sell	3,843,522 -56,644	-1%	-$2.88M	0.03%	535
2014 Q2	$197M	Sell	3,900,166 -76,866	-2%	-$3.81M	0.03%	534
2014 Q1	$178M	Buy	3,977,032 +84,789	+2%	+$3.81M	0.03%	576
2013 Q4	$183M	Buy	3,892,243 +135,054	+4%	+$6.84M	0.03%	540
2013 Q3	$198M	Sell	3,757,189 -224,382	-6%	-$10.9M	0.04%	467
2013 Q2	$180M	Buy	+3,981,571	New	+$189M	0.04%	481

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock Institutional Trust's RMD Position: Q4 2016 in Review

BlackRock Institutional Trust increased its ResMed (RMD) stake by 5.2% in Q4 2016, buying an estimated $13.8M and bringing the position to 4,566,701 shares worth $283M. The position accounts for 0.04% of the portfolio, ranked #440.

BlackRock Institutional Trust first reported a position in RMD in Q2 2013 and has held it in 15 quarters since. The position peaked at $291M in Q1 2015. 362 funds tracked by Wall St. Rank hold RMD as of Q4 2016.

BlackRock Institutional Trust held 4,566,701 shares of ResMed worth $283M as of Q4 2016.
BlackRock Institutional Trust bought 225,088 ResMed shares in Q4 2016, an estimated $13.8M.
ResMed made up 0.04% of BlackRock Institutional Trust's portfolio in Q4 2016, its #440 holding.
BlackRock Institutional Trust first reported a position in ResMed in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's ResMed position peaked at $291M in Q1 2015.
362 funds tracked by Wall St. Rank held ResMed as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.